OCT in cooperation with the Russian Corporation of Nanotechnologies (RUSNANO) offer nanotech, biotech, medtech, pharma, and
health industry companies the following possibilities to succeed in projects on development of new nanodrugs and nanodiagnostics:
- Joint financing II-III Phase clinical investigations involving the investments from RUSNANO
- Financing start-up projects of I-IV Phase clinical studies (obtaining regulatory approval) out of the proceeds of OCT
- Flexibility in choosing financial investment instruments for the project: equity, loans, leasing, etc.
- Providing proper project feasibility study to commercialize nanotech project results in Russian market
Please look through the brief presentation Commercialize your R&D projects results in Nanomedicine & Nanodiagnostics and let us know if you are interested in collaboration.
|
DOWNLOAD PRESENTATION
|
СКАЧАТЬ ПРЕЗЕНТАЦИЮ |
|||
 |
 |
|
|
|
| PDF (239 kb) |
Power Point Slideshow (1650 kb) |
PDF (226 kb) |
Power Point Slideshow (1002 kb) |
|
